Precision Therapeutics Inc. (NASDAQ:AIPT)
Precision Therapeutics Inc. (NASDAQ:AIPT) represented a move of 0 percent or $0.01 per share and closed its previous day trading session at $0.78. 0 Shares were traded in the last trading session with an Average Volume of 72.76 Million Shares. The stock currently has a Market Capitalization of 10.98 Million.
Precision Therapeutics Inc. operating business areas includes development of a healthcare CRO which provides personalized medicine solutions for clients in the pharmaceutical, diagnostic and biotech industries as well as production of the FDA-approved STREAMWAY(R) System for automated, direct-to-drain medical fluid disposal. Precision Therapeutics Inc., formerly known as Skyline Medical Inc, is based in MINNEAPOLIS.
The stock traded between $0.710 and $1.580 over 1-Year time period showing its price to sales ratio of 8.45. Precision Therapeutics Inc. (NASDAQ:AIPT) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-12.38 and 200-Day Simple Moving Average of $-25.91. Its Price to Free Cash Flow is 0 and Price to Book of 3.39.
Analyst’s recommended the stock as 0 where 1 represents Strong Buy and 5 represents Sell.
General Moly, Inc (NYSE:GMO)
In the last trading session, General Moly, Inc (NYSE:GMO) added its value by 0% closing at the price of $0.16. The stock currently has market capitalization of 23.3 Million, with average volume of 327.05 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently General Moly, Inc (NYSE:GMO) is showing beta of 2.21. This particular value of beta suggests that General Moly, Inc (NYSE:GMO) has historically moved 221% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for General Moly, Inc (NYSE:GMO) is at $-0.08.
The stock currently has RSI of 26.07. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
General Moly is a U.S.-based molybdenum mineral exploration and development company listed on the American Stock Exchange and the Toronto Stock Exchange under the symbol GMO. Their primary asset, their interest in the Mt. Hope project located in central Nevada, is considered one of the world’s largest and highest grade molybdenum deposits. Combined with their second molybdenum property, the Hall-Tonopah project which is also located in central Nevada. Their goal is to become the largest primary molybdenum producer by the middle of the next decade.
General Moly, Inc (NYSE:GMO) topped its 52-week high price of $0.460 on 08/24/18 and 52-Week Low Price of $0.160 on 11/29/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 9.03% and monthly volatility of 9.08% respectively.